Overview

Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain

Status:
Not yet recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
To compare the effect of intraoperative intracameral Omidria (Phenylephrine and Ketorolac 1.0%/0.3%) verses 1% Lidocaine on pain reduction during and after cataract surgery.
Phase:
Phase 4
Details
Lead Sponsor:
University of Florida
Collaborator:
Omeros Corporation
Treatments:
Ketorolac
Lidocaine
Oxymetazoline
Phenylephrine